Welcome to CDC Stacks | Evolution of Cryptococcal Antigen Testing: What is new? - 39436 | CDC Public Access

Welcome to CDC Stacks | Evolution of Cryptococcal Antigen Testing: What is new? - 39436 | CDC Public Access

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

information icon

information icon

information icon

Clear All Simple Search

Advanced Search

delete_icon

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Evolution of Cryptococcal Antigen Testing: What is new?

Published Date:

2016

Publisher's site:

http://dx.doi.org/10.1007/s12281-016-0256-3 New Site Icon

Source:

Curr Fungal Infect Rep. 2016:1-6.

[PDF - 103.15 KB]

Details:

Personal Authors:

Nalintya, Elizabeth ; Kiggundu, Reuben ; Meya, David ;

Keywords:

[+]

Pubmed ID:

27158322

Pubmed Central ID:

PMC4858186

Description:

Over the last decade, an upsurge in both the frequency and severity of fungal infections due to the HIV/AIDS epidemic and the use of immunosuppressive therapy has occurred. Even diagnostic methods like culture and microscopy, which have low sensitivity and longer turn-around-times are not widely available, leading to delays in timely antifungal therapy and detrimental patient outcomes. The evolution of cryptococcal antigen (CrAg) testing to develop inexpensive and more sensitive methods to detect cryptococcal antigen is significant. These newer tests employ immunoassays as part of point-of-care platforms, which do not require complex laboratory infrastructure and they have the potential to detect early disease and reduce time to diagnosis of cryptococcal infection. Advocacy for widely available and efficacious life-saving antifungal treatment should be the only remaining challenge.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

U01 GH000517/GH/CGH CDC HHS/United States

Supporting Files:

nihms-777332.nxml

application/octet-stream

No Related Documents.

You May Also Like:

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam

Personal Author:

Smith, Rachel M.; Nguyen, Tuan Anh; Ha, Hoang Thi Thanh; Thang, Pham Hong; Thuy, Cao; Xuan Lien, Truong; Bui, Hien T.; Le, Thai Hung; Struminger, Bruce; McConnell, Michelle S.; Fanfair, Robyn Neblett; Park, Benjamin J.; Harris, Julie R.;

Published:

Apr 23 2013

Source:

PLoS One. 2013; 8(4).

Description:

Background : An estimated 120,000 HIV-associated cryptococcal meningitis (CM) cases occur each year in South and Southeast Asia; early treatment may improve outcomes. The World Health Organization (WHO) recently recommended screening HIV-infected adu...

File Type:

[PDF - 374.29 KB]
Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast

Personal Author:

Boulware, David R.; Rolfes, Melissa A.; Rajasingham, Radha; von Hohenberg, Maximilian; Qin, Zhenpeng; Taseera, Kabanda; Schutz, Charlotte; Kwizera, Richard; Butler, Elissa K.; Meintjes, Graeme; Muzoora, Conrad; Bischof, John C.; Meya, David B.;

Published:

Jan 2014

Source:

Emerg Infect Dis. 20(1):45-53.

Description:

Cryptococcal meningitis is common in sub-Saharan Africa. Given the need for data for a rapid, point-of-care cryptococcal antigen (CRAG) lateral flow immunochromatographic assay (LFA), we assessed diagnostic performance of cerebrospinal fluid (CSF) cu...

File Type:

[PDF - 458.51 KB]
Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100

Personal Author:

Kwizera, Richard; Nguna, Joyce; Kiragga, Agnes; Nakavuma, Jesca; Rajasingham, Radha; Boulware, David R.; Meya, David B.;

Published:

Jul 31 2014

Source:

PLoS One. 2014; 9(7).

Description:

Background : Cryptococcal meningitis can best be diagnosed by cerebrospinal fluid India ink microscopy, cryptococcal antigen detection, or culture. These require invasive lumbar punctures. The utility of cryptococcal antigen detection in saliva is un...

File Type:

[PDF - 213.17 KB]
What is sepsis?

Corporate Author:

Centers for Disease Control and Prevention (U.S.)

Published:

8/19/2016

Description:

Sepsis is a complication caused by the body’s overwhelming and life-threatening response to infection, which can lead to tissue damage, organ failure, and death. : Publication date from document properties. : sepsis_infographic_final.pdf

File Type:

[PDF - 243.38 KB]
Evolution of New Genotype of West Nile Virus in North America

Personal Author:

McMullen, Allison R.; May, Fiona J.; Li, Li; Guzman, Hilda; Bueno, Rudy; Dennett, James A.; Tesh, Robert B.; Barrett, Alan D.T.;

Published:

May 2011

Source:

Emerg Infect Dis. 17(5):785-793.

Description:

Previous studies of North American isolates of West Nile virus (WNV) during 1999-2005 suggested that the virus had reached genetic homeostasis in North America. However, genomic sequencing of WNV isolates from Harris County, Texas, during 2002-2009 s...

File Type:

[PDF - 496.56 KB]